SpaceOAR® Hydrogel

Augmenix

Booth: 3133

SpaceOAR® hydrogel is a prostate rectum spacer that separates and protects the rectum during prostate radiotherapy. The hydrogel spacer provides a barrier between the prostate and rectum to decrease rectal toxicity and minimize changes in quality of life (QOL) following prostate radiotherapy. The 3-year follow-up study results of a Phase 3 clinical trial demonstrated a significant reduction in late rectal toxicity (78%) along with favorable bowel, urinary and sexual QOL measurements. SpaceOAR hydrogel is placed via a transperineal injection, the procedure can be performed in an in-office setting under local anesthesia and is reimbursed under CPT® code 55874. SpaceOAR System is FDA cleared, CE marked, approved in Australia and Japan and licensed in Canada.

BrachytherapyMedical Device and EquipmentRadiation Protection/ShieldingRadiation Therapy


Video










Request Information





By requesting information, you agree to share the email you provided at the time of registration with the exhibitor for follow-up. Click on “Submit” to share your email or “Cancel” to cancel your information request.